151 related articles for article (PubMed ID: 27957363)
1. Aseptic Meningitis Caused by Lassa Virus: Case Series Report.
Okokhere PO; Bankole IA; Iruolagbe CO; Muoebonam BE; Okonofua MO; Dawodu SO; Akpede GO
Case Rep Neurol Med; 2016; 2016():1978461. PubMed ID: 27957363
[TBL] [Abstract][Full Text] [Related]
2. Acute Lassa Virus Encephalitis with Lassa Virus in the Cerebrospinal Fluid but Absent in the Blood: A Case Report with a Positive Outcome.
Okokhere PO; Erameh CO; Alikah F; Akhideno PE; Iruolagbe CO; Osazuwa OO; Bankole IA; Adomeh DI; Odia I; Aire CO; Oyakhilome J; Agbukor J; Atafo RO; Asogun DA; Happi CT; Sabeti PC; Günther S; Akpede GO
Case Rep Neurol; 2018; 10(2):150-158. PubMed ID: 30057542
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.
Asogun DA; Adomeh DI; Ehimuan J; Odia I; Hass M; Gabriel M; Olschläger S; Becker-Ziaja B; Folarin O; Phelan E; Ehiane PE; Ifeh VE; Uyigue EA; Oladapo YT; Muoebonam EB; Osunde O; Dongo A; Okokhere PO; Okogbenin SA; Momoh M; Alikah SO; Akhuemokhan OC; Imomeh P; Odike MA; Gire S; Andersen K; Sabeti PC; Happi CT; Akpede GO; Günther S
PLoS Negl Trop Dis; 2012; 6(9):e1839. PubMed ID: 23029594
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.
Okokhere P; Colubri A; Azubike C; Iruolagbe C; Osazuwa O; Tabrizi S; Chin E; Asad S; Ediale E; Rafiu M; Adomeh D; Odia I; Atafo R; Aire C; Okogbenin S; Pahlman M; Becker-Ziaja B; Asogun D; Fradet T; Fry B; Schaffner SF; Happi C; Akpede G; Günther S; Sabeti PC
Lancet Infect Dis; 2018 Jun; 18(6):684-695. PubMed ID: 29523497
[TBL] [Abstract][Full Text] [Related]
5. Lassa Fever Natural History and Clinical Management.
Grant DS; Samuels RJ; Garry RF; Schieffelin JS
Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159
[TBL] [Abstract][Full Text] [Related]
6. Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report.
Agboeze J; Nwali MI; Nwakpakpa E; Ogah OE; Onoh R; Eze J; Ukaegbe C; Ajayi N; Nnadozie UU; Orji ML; Ojide KC; Unigwe SU; Chika-Igwenyi N; Nwidi DU; Clement CU; Kalombo C; Makwe C; Tshiang J
Int J Infect Dis; 2019 Dec; 89():84-86. PubMed ID: 31465848
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.
Groger M; Akhideno P; Kleist CJ; Babatunde FO; Edeawe O; Hinzmann J; Akhigbe T; Nwatuzor J; Eifediyi G; Müller J; Hinrichs M; Pahlmann M; Sarpong FN; Wagner C; Thielebein A; Aihonwalan L; Koch T; Riedner M; Ogbaini-Emovon E; Okogbenin S; Günther S; Wicha SG; Ramharter M; Oestereich L; Duraffour S; Erameh C
Clin Infect Dis; 2023 Feb; 76(3):e841-e848. PubMed ID: 35881530
[TBL] [Abstract][Full Text] [Related]
8. Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE).
Duvignaud A; Jaspard M; Etafo IC; Serra B; Abejegah C; Gabillard D; Doutchi M; Alabi JF; Adedokun MA; Akinpelu AO; Oyegunle OO; Etafo J; Dede AO; Onyechi MN; Ireneh MU; Gbenga-Ayeni O; Fadiminiyi KG; Ehigbor PI; Ouattara E; Levy-Marchal C; Karcher S; N'guessan-Koffi L; Ahyi I; Amani E; Diabaté M; Siloué B; Schaeffer J; Augier A; Ogbaini-Emovon E; Salam AP; Horby P; Ahmed LA; Günther S; Adedosu AN; Anglaret X; Ayodeji OO; Malvy D
Travel Med Infect Dis; 2020; 36():101557. PubMed ID: 31978611
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
[TBL] [Abstract][Full Text] [Related]
10. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D;
Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408
[TBL] [Abstract][Full Text] [Related]
11. Lassa fever presenting as acute abdomen: a case series.
Dongo AE; Kesieme EB; Iyamu CE; Okokhere PO; Akhuemokhan OC; Akpede GO
Virol J; 2013 Apr; 10():123. PubMed ID: 23597024
[TBL] [Abstract][Full Text] [Related]
12. Imported Lassa fever: a report of 2 cases in Ghana.
Kyei NN; Abilba MM; Kwawu FK; Agbenohevi PG; Bonney JH; Agbemaple TK; Nimo-Paintsil SC; Ampofo W; Ohene SA; Nyarko EO
BMC Infect Dis; 2015 May; 15():217. PubMed ID: 26022703
[TBL] [Abstract][Full Text] [Related]
13. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
[TBL] [Abstract][Full Text] [Related]
14. Re-emergence of Lassa fever in Nigeria: A new challenge for public health authorities.
Naeem A; Zahid S; Hafeez MH; Bibi A; Tabassum S; Akilimali A
Health Sci Rep; 2023 Oct; 6(10):e1628. PubMed ID: 37885466
[TBL] [Abstract][Full Text] [Related]
15. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
[TBL] [Abstract][Full Text] [Related]
16. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum.
Günther S; Weisner B; Roth A; Grewing T; Asper M; Drosten C; Emmerich P; Petersen J; Wilczek M; Schmitz H
J Infect Dis; 2001 Aug; 184(3):345-9. PubMed ID: 11443561
[TBL] [Abstract][Full Text] [Related]
17. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases.
Wolf T; Ellwanger R; Goetsch U; Wetzstein N; Gottschalk R
J Travel Med; 2020 Jul; 27(4):. PubMed ID: 32219400
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
[TBL] [Abstract][Full Text] [Related]
19. Lassa virus infection in Nigeria: clinical perspective overview.
Idemyor V
J Natl Med Assoc; 2010 Dec; 102(12):1243-6. PubMed ID: 21287906
[TBL] [Abstract][Full Text] [Related]
20. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
